![James Stonecypher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Stonecypher
Corporate Officer/Principal bij
TELIX PHARMACEUTICALS LIMITED
Profiel
James Stonecypher currently works at Object Pharma, Inc., as Chief Executive Officer and Telix Pharmaceuticals Ltd., as Chief Development Officer from 2023.
Mr. Stonecypher received his undergraduate degree from the University of Southern California and graduate degree from The Johns Hopkins University.
Actieve functies van James Stonecypher
| Bedrijven | Functie | Begin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01-12-2022 |
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Algemeen Directeur | - |
Opleiding van James Stonecypher
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Innovates neurotoxins | Health Technology |
